Virtual Clinical Trials – Thematic Research

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Virtual Clinical Trials Market Overview

Virtual clinical trials, also commonly referred to as decentralized clinical trials (DCTs), use digital technologies and other processes that differ from traditional trial models to bring research closer to patient’s homes in order to increase access to trials, as well as reduce inconvenience and burden on participants by decreasing the number of physical site visits. Virtual trials are also known as remote, siteless, hybrid, or digital trials. The examples of digital technologies used in virtual trials includes eConsent, telemedicine, electronic clinical outcome assessment (eCOA), remote patient monitoring (RPM), mobile health (mHealth), wearables, and digital biomarker collection.

An increasing number of trials were using virtual components before the COVID-19 pandemic. COVID-19 lockdowns and social distancing measures caused significant disruption to clinical trials and accelerated the use of virtual trials. Companies that had not considered this model before had no option but to rapidly implement new technologies and procedures to maintain business continuity. Research shows that many companies will continue to use virtual trials after the pandemic. Over the past 18 months, many leading clinical research organizations (CROs) and eClinical software providers have expanded their capabilities in response to the growing demand for these services. Several specialist virtual trial providers have also emerged in recent years and attracted considerable attention during the pandemic.

What are the key technology trends in the virtual clinical trials MARKET?

Wearable technology: Significant developments have occurred in wearable devices and sensors that continuously monitor and collect patient data in a convenient and non-invasive manner. Trial participants can use smartwatches, skin patches, and even smart clothing to monitor measurements such as heart rate, blood pressure, oxygen saturation, respiratory rate, ECG, and glucose levels, as well as movement-based metrics such as tremor, gait, and seizures. These devices can be paired with virtual trial platforms or other eClinical software to track and store patient data, which can then be reviewed and analyzed by research staff and investigators.

mHealth: Wearable devices, smartphones, tablets, and mobile apps are form a core part of virtual trial technology. Apps are used throughout the virtual trial value chain, such as for patient recruitment and enrolment, eConsent, collection of eCOA and data from connected devices, patient communication and engagement, micro-reimbursements, facilitating telehealth visits with investigators. Most players in the virtual trials space provide their patient-facing services on customizable and compliant app-based platforms for their clients, ensuring that the patient experience is convenient, seamless, and secure.

Telemedicine: Telemedicine became an invaluable tool during the COVID-19 pandemic, allowing patients to connect with and receive care from providers while maintaining safety and minimizing risk of transmission. Telemedicine was thus found to be a key technology that was used to mitigate the impact of the COVID-19 pandemic on clinical trial disruptions.

Cloud computing: The use of cloud-based virtual trial platforms allows for the robust and secure collection and synchronization of vast amounts of data from multiple disparate sources, interoperability between different eClinical software systems, secure single access for study teams, and support for advanced analytics and insight generation. It also allows for the rapid scale-up of trials to serve a large number of patients and the use of multiple.

5G: 5G networks will allow for the use of more connected devices in trials, with enhanced collection of data from wearables and other sensor-based devices. Additionally, 5G will lead to improved delivery tracking and monitoring of cold-chain environments for direct-to-patient investigational medicines.

Artificial intelligence: AI and its application in data analytics have the potential to enhance many aspects of the virtual trial value chain. For example, AI can be used to enhance clinical trial design, identify hypotheses, and minimize potential risks. Machine learning (ML) and natural language processing can be used in participant recruitment by using EHRs and data from connected devices to match patients with trials, and then recommend these trials to the patient or their physician. Given the vast amount of data generated from many different digital sources in virtual trials, AI allows the large-scale mining and advanced analysis of these large data sets to identify trends, flag issues, and enhance interpretations of trial findings.

What are the value chain segments in the virtual clinical trials?

The virtual clinical trials value chain can be broadly split into the following categories: study start-up, trial operations, patient monitoring, and patient data management including electronic data collection (EDC) systems.

What is the impact of COVID-19 on virtual clinical trials?

While levels of disruption have fallen since June 2020, clinical trials are likely to remain disrupted by COVID-19 throughout 2021. The drug development was found to be the most impacted area of the pharma value chain in 2021.

Which are the public and private key players involved in the virtual clinical trials?

The leading public companies includes the Catalent Inc., IBM, Lash Group, Oracle, PRA Health Sciences, Science 37, Syneos Health Inc, Thermo Fisher Scientific Inc., Veeva and World Courier. The examples of private companies include Castor, Covance Inc., DHL, ERT, Marken, Medable, Medical Research Network Ltd., ObvioHealth and Parexel International Corp.

Virtual clinical trials market, by key players

Virtual clinical trials market, by key players

To know more about key players, download a free report sample

Market report scope

Public Companies Catalent Inc., IBM, Lash Group, Oracle, PRA Health Sciences, Science 37, Syneos Health Inc, Thermo Fisher Scientific Inc., Veeva and World Courier.
Private Companies Castor, Covance Inc., DHL, ERT, Marken, Medable, Medical Research Network Ltd., ObvioHealth and Parexel International Corp

Scope

  • Key players in the virtual trial space: These include specialist virtual trial providers, CROs, eClinical solution providers, technology companies, contract development and manufacturing organizations (CDMOs), logistics companies, and in-home care providers.
  • Thematic briefing including a definition of virtual trials and the different technologies and processes used, such as eConsent, eCOA, telemedicine, direct-to-patient supply, and in-home care, as well as a review of the benefits and challenges to implementing these types of studies.
  • Key trends impacting the virtual trial space. Industry trends include the impact of COVID-19 on clinical trials and digital transformation in pharma, rise of the virtual trials specialists and the evolution of CROs, positive impact of virtual trials on accrual rates, and increased focus on patient centricity in trials.
  • Technology trends include the role of wearable technology, mHealth, telemedicine, cloud, 5G, blockchain, cybersecurity, and artificial intelligence.
  • Regulatory trends include the lack of regulatory frameworks for virtual trials, guidelines issues during COVID-19 to support continuation of clinical research, and the role of non-profit organizations such as the DTRA and CTTI in guiding companies to implement virtual trials. Macroeconomic trends including the increase seen in deals and jobs related to virtual trials since COVID-19.
  • Value chain looking at certain aspects of virtual trials, including eConsent, eCOA, telemedicine, direct-to-patient supply, and in-home care.
  • Industry analysis with a detailed analysis of virtual trials deals from the Clinical Trials database, as well comprehensive deals, jobs, and Influencer analyses. This section also includes case studies and survey and poll data.
  • Profiles of private and public companies in the virtual trials space.

Reasons to Buy

  • See who the leading players are in the virtual trials space by company type.
  • See how the competitive landscape is evolving, with a review of company activity including mergers and acquisitions (M&A), strategic partnerships and funding deals, as well as a jobs analysis.
  • See what trends are driving the use of virtual trials, and what challenges are impeding their uptake
  • See which technologies and processes are being used to bring research closer to patients.
  • Get a deep dive into clinical trial data, including the impact of COVID-19 on trials, the use of virtual components in trials over the past decade, and how virtual trials have improved trial accrual rates.

 

Medable
Science 37
THREAD
ObvioHealth
Studies&Me
Lightship
Parexel
Pharmaceutical Product Development (PPD)
Covance
ICON
Syneos Health
UBC
Medidata
ERT
Signant Health
Medrio
Castor
Cloudbyz
TrialSpark
uMotif
AiCure
snapIoT
IBM
Veeva
DHL
World Courier
Marken
Yourway
Illingworth Research
Lash Group
Medical Research Network

Table of Contents

Executive Summary

Players

Thematic Briefing

Trends

• Healthcare Trends

• Technology Trends

• Regulatory trends

• Macroeconomic Trends

Value Chain

• eConsent

• Electronic Clinical Outcome Assessment

• Telemedicine

• In-Home Care

• Direct-to-Patient Supply

Industry Analysis

• The Impact of COVID-19 on Clinical Trials

• Virtual Clinical Trials Analysis

• Impact of Virtual Trials on Trial Accrual Rates

• Survey Data on the Adoption of Virtual Trials

Deals Analysis

• Mergers and Acquisitions

• Strategic Partnerships

• Funding Deals

Jobs Analysis

Case Studies

• The First Virtual Trial, Pfizer’s REMOTE, Was Terminated Due to Low Accrual Rates

• Specialist Vendor Science 37 Is Pioneering the Virtual Trials Space

• PPD Has Partnered with Specialists to Become a Leading Provider of Virtual Trials During the Pandemic

• LEO Innovation Lab Spin-Off Studies&Me Launches as a Virtual CRO With a Focus in Dermatology

• J&J Goes Virtual in Cardiology with its Heartline and CHIEF-HF Trials

Timeline

Healthcare Industry Polls

Social Media Influencers

Companies

• Public Companies

• Private Companies

Appendix

• Abbreviations

• Further Reading

• Related Reports

• Bibliography

• About the Authors

• Our Thematic Research Methodology

• About GlobalData

• Contact Us

Frequently asked questions

Virtual Clinical Trials – Thematic Research thematic reports
Currency USD
$995

Can be used by individual purchaser only

$1,995

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Virtual Clinical Trials – Thematic Research was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Virtual Clinical Trials – Thematic Research in real time.

  • Access a live Virtual Clinical Trials – Thematic Research dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.